Loading clinical trials...
Loading clinical trials...
Fluconazole is the first-line agent in the treatment of invasive candidiasis. Studies showed inappropriate drug exposure causes high mortality in critically ill patients. Under-dosing and ineffective ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Medical Center Groningen
NCT05763251 · Invasive Candidiasis
NCT03538912 · Invasive Candidiasis
NCT04368559 · Candidemia, Mycoses, and more
NCT02164890 · Invasive Candidiasis
NCT02801682 · Invasive Candidiasis
University Medical Center Groningen
Groningen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions